VeraMorph Awarded an SBIR Fast Track Grant by NCI Towards Commercialization of the First Effective Oral Fulvestrant Therapy for ER+ Metastatic Breast Cancer

Published on October 15, 2025

Oct 15, 2025-- Veramorph LLC ( VeraMorph ), a science-driven startup developing a novel degradable gel as a solubility-enhancing oral drug

Continue reading on website
Other news

Grateful secures £1.5m to transform tipping for frontline workers

October 15, 2025
Grateful has raised £1.5 million ($2m) in seed funding from Calculus Capital to accelerate development of its automated tip pooling and

Arts Professional: Creative Sector Must ‘Come Together’ to Give Artists Easier Access to Visas

October 15, 2025
to reduce immigration, there is recognition that diversity of talent is essential for the UK’s creative industries. Read more here (please